发明名称 SUBSTITUTED PYRROLO]2,3-D]PYRIMIDINES
摘要 The present disclosure relates to compounds of formula (I-A) using the compounds;;wherein Ring A and the variables X, Y, R3a, R3b, R3c, R3d, R4, R5, R5′, and m are defined herein, to pharmaceutical compositions comprising the compounds, and methods of using the compounds.
申请公布号 US2014256668(A9) 申请公布日期 2014.09.11
申请号 US201313901006 申请日期 2013.05.23
申请人 MILLENNIUM PHARMACEUTICALS, INC. 发明人 CRITCHLEY Stephen;Gant Thomas G.;Langston Steven P.;Olhava Edward J.;Peluso Stephane
分类号 C07H19/16;C07D473/00;C07D471/04;C07H19/14;C07H19/048 主分类号 C07H19/16
代理机构 代理人
主权项 1. A compound of formula (I-A): or a pharmaceutically acceptable salt thereof, wherein: Ring A is: wherein one ring nitrogen atom in Ring A optionally is oxidized; X is —CH2—, —CHF—, —CF2—, —NH—, or —O—; Y is —O—, —S—, or —C(Rm)(Rn)—; each Rh independently is hydrogen, halo, —CN, —OH, —O—(C1-4 aliphatic), —NH2, —NH—(C1-4 aliphatic), —N(C1-4 aliphatic)2, —SH, —S—(C1-4 aliphatic), or an optionally substituted C1-4 aliphatic group; Rj is hydrogen, —OR5, —SR6, —N(R4)2, or an optionally substituted aliphatic, aryl, or heteroaryl group; Rk is hydrogen, halo, —OR5, —SR6, —N(R4)2, or an optionally substituted C1-4 aliphatic group; Rm is hydrogen, fluoro, —N(R4)2, or an optionally substituted C1-4 aliphatic group, and Rn is hydrogen, fluoro, or an optionally substituted C1-4 aliphatic group, or Rm and Rn together form ═O or ═C(R5)2; R1 is hydrogen, chloro, bromo, fluoro, iodo, —NR7R8, —R9, —SH, —SCH3, —S—R10, —OH, —OCH3, or —O—R11; R2 is hydrogen, chloro, bromo, fluoro, iodo, —N(R6)2, —CN, —O—(C1-4 aliphatic), —OH, —SR6, or an optionally substituted C1-4 aliphatic group; R3a is hydrogen, fluoro, —CN, —N3, hydroxy, —OR21, —NH2, —NH(R21), —N(H)CO2R21, —N(H)C(O)R21, —CON(H)R21, —C(O) R5, —OC(O)N(H)R21, —OC(O)R21, —OC(O)OR21, —C1-4 fluoroaliphatic, or a —C1-4 aliphatic optionally substituted with one or two substituents independently selected from the group —OR5x, —N(R4x)(R4y), —CO2R5x, and —C(O)N(R4x)(R4y); R3b is hydrogen, fluoro, C1-4 aliphatic, or C1-4 fluoroaliphatic; R3c is hydrogen, fluoro, —CN, —N3, hydroxy, —OR21, —NH2, —NH(R21), —N(H)CO2R21, —N(H)C(O)R21, —CON(H)R21, —OC(O)N(H)R21, —OC(O)R21, —OC(O)OR21, —C1-4 fluoroaliphatic, or a —C1-4 aliphatic optionally substituted with one or two substituents independently selected from the group —OR5x, —N(R4x)(R4y), —CO2R5x, and —C(O)N(R4x)(R4y); R3d is hydrogen, fluoro, C1-4 aliphatic, or C1-4 fluoroaliphatic; each R4 is independently hydrogen, fluoro, C1-4 aliphatic, or C1-4 fluoroaliphatic; or two R4, taken together with the carbon atom to which they are attached, form a 3- to 6-membered carbocyclic ring; or one R4, taken together with R5 and the intervening carbon atoms, forms a 3- to 6-membered spirocyclic ring; or two R4 together form ═O; R5 is hydrogen, or C1-4 aliphatic; or R5, taken together with one R4 and the intervening carbon atoms, forms a 3- to 6-membered spirocyclic ring; R5′ is hydrogen, or C1-4 aliphatic; each R6 is independently hydrogen or C1-4 aliphatic; R7 is an optionally substituted C1-10 aliphatic, aryl, heteroaryl, or heterocyclyl group; R8 is hydrogen or C1-4 aliphatic; R9 is —V—Z—R12a, —V—Z—R12b, —R12c, or an optionally substituted aliphatic, aryl, heterocyclyl, or heteroaryl group, wherein the heteroaryl group is attached at a carbon atom; R10 is an unsubstituted C2-10 aliphatic, a substituted C1-10 aliphatic, or an optionally substituted aryl, heteroaryl, or heterocyclyl; R11 is an unsubstituted C2-10 aliphatic, a substituted C1-10 aliphatic, or an optionally substituted aryl, heteroaryl, or heterocyclyl; R4x is hydrogen, C1-4 alkyl, C1-4 fluoroalkyl, or C6-10 ar(C1-4)alkyl, the aryl portion of which may be optionally substituted; R4y is hydrogen, C1-4 alkyl, C1-4 fluoroalkyl, C6-10 ar(C1-4)alkyl, the aryl portion of which may be optionally substituted, or an optionally substituted 5- or 6-membered aryl, heteroaryl, or heterocyclyl ring; or R4x and R4y, taken together with the nitrogen atom to which they are attached, form an optionally substituted 4- to 8-membered heterocyclyl ring having, in addition to the nitrogen atom, 0-2 ring heteroatoms independently selected from N, O, and S; each R5x independently is hydrogen, C1-4 alkyl, C1-4 fluoroalkyl, or an optionally substituted C6-10 aryl or C6-10 ar(C1-4)alkyl; V is —S(O)2—, —S(O)—, —C(O)O—, —C(O)—, —C(NR13)═N—, —C(═N(R13))—N(R13)—, —C(OR11)═N—, —CON(R13)—, —N(R13)C(O)—, —N(R13)C(O)N(R13)—, —N(R13)S(O)2, —N(R13)SO2—N(R13)—, —N(R3)CO2—, —SO2N(R13)—, —OC(O)—, —OC(O)O—, —OC(O)N(R13)—, or —N(R13)—N(R13)—; Z is an optionally substituted C1-6s alkylene chain, wherein the alkylene chain is optionally interrupted by —C(R13)═C(R13)—, —C≡C—, —O—, —S—, —N(R13)—, —N(R13)CO—, —N(R13)CO2—, —C(O)N(R13)—, —C(O)—, —C(O)—C(O)—, —CO2—, —OC(O)—, —OC(O)O—, —N(R13)C(O)N(R13)—, —N(R13) N(R13)—, —OC(O)N(R13)—, —S(O)—, —S(O)2—, —N(R13)S(O)2—, or —S(O)2N(R13)—; R12a is an optionally substituted aryl, heteroaryl, heterocyclyl, or cycloaliphatic group; R12b is halo, —NO2, —CN, —OR14, —SR15, —N(R16)2, —N(R16)C(O)R15, —N(R16)C(O)N(R6)2, —N(R16)CO2R14, —O—CO2—R14, —OC(O)N(R16)2, —OC(O)R14, —N(R16)—N(R16)2, —N(R16)—O R15, —N(R16)S(O)2R15, ef —N(R16)SO2—N(R16)2, —C(R4)═C(R14)2, —C≡C-R14, —S(O)R15, —SO2R15, —SO2—N(R16)2, —C(R14)═N—OR4, —CO2R14, —C(O)—C(O)R14, —C(O)R14, —C(O)N(R16)2, —C(═NR16)—N(R16)2, or —C(═NR16)—OR14; R12c is —NO2, —CN, —S(O)R15, —SO2R15, —SO2—N(R16)2, —C(R14)═N—OR14, —N(R16)C(O)R15, —N(R16)C(O)N(R16)2, —O—CO2—R14—, —OC(O)N(R16)2, —OC(O)R14, —CO2R14, —C(O)—C(O)R14, —C(O)R14, —C(O)N(R16)2, —C(═NR11)—N(R16)2, —C(═NR16)—OR14, —N(R16)—N(R16)2, —N(R16)—OR15, —N(R16)S(O)2R15, or —N(R16)SO2N(R16)2; each R13 is independently hydrogen, or an optionally substituted aliphatic, aryl, heteroaryl, or heterocyclyl group; each R14 independently is hydrogen, or an optionally substituted aliphatic, aryl, heteroaryl, or heterocyclyl group; each R15 independently is an optionally substituted aliphatic, or aryl group; each R16 independently is an optionally substituted aliphatic, aryl, heteroaryl, or heterocyclyl group; or two R16 on the same nitrogen atom, taken together with the nitrogen atom, form an optionally substituted five to eight membered heterocylyl ring having, in addition to the nitrogen atom, zero to two additional ring heteroatoms selected from the group N, O, and S; each R21 independently is an optionally substituted C1-10 aliphatic, aryl, heteroaryl, or heterocyclyl group; and m is 1, 2, or 3; provided that: if Ring A is A-i, X is —O—, Y is —O— or —CH2—, R2 is hydrogen or chloro, R3a is hydroxyl or —OCOR21, R3b is hydrogen, R3c is hydroxyl or —OCOR21, R3d is hydrogen, R4 and R5 are each hydrogen, and m is 1; then R1 is bromo, fluoro, —NR7R8, —R9, —SR10, or —OR11, R7 is a substituted aliphatic, or an optionally substituted aryl, heteroaryl, aralkyl, heteroaralkyl, cycloaliphatic, heterocyclyl, (cycloaliphatic)alkyl, or (heterocyclyl)alkyl, and R9 is other than unsubstituted imidazole.
地址 Cambridge MA US